Log in or Sign up for Free to view tailored content for your specialty!
Geriatrics News
Organization works to address minority underrepresentation in Alzheimer’s research
Us Against Alzheimer’s recently launched an engagement strategy to establish a national network of diverse researchers, patients, caregivers and stakeholder groups to address the underrepresentation of blacks and Latinos in neurological research.
FDA grants 501(k) clearance to mobile memory test
Cambridge Cognition recently announced the FDA granted 501(k) clearance to market CANTAB Mobile, a computerized test of visuospatial associative learning, as a medical device in the US.
Log in or Sign up for Free to view tailored content for your specialty!
Delirium increases cognitive decline in dementia
Cognitive decline was greater among individuals with delirium and pathologic processes of dementia than those with delirium or dementia individually, according to recent findings.
Concussions may increase risk for Alzheimer's disease
Mild traumatic brain injury was associated with cortical thinning in brain regions associated with early Alzheimer’s disease among veterans with PTSD.
Study questions link between glaucoma, Alzheimer's disease
KOLOA, Hawaii — Recent findings presented here found comparable cognitive functioning between individuals with glaucoma and healthy controls, suggesting glaucoma is not associated with cognition in Alzheimer’s disease.
Top 5 articles for psychiatrists who treat the elderly
More than 20% of adults aged 60 years and older have a mental or neurological disorder and 6.6% of all disability-adjusted life years in this age group are attributed to neurological and mental health disorders, according to WHO.
Cognitive training app effective for moderate, late-life depression
A mobile cognitive training app for depression may be effective for moderate and late-life depression, according to recent findings.
Deep TMS effective for treatment-resistant depression in elderly
Brainsway recently announced positive study findings for deep transcranial magnetic stimulation for treatment-resistant depression in elderly adults.
Sniff test accurately screens for early Alzheimer's disease
Odor identification may be an accurate and useful supplement to Alzheimer’s disease screening, according to recent findings.
Antipsychotic use in Alzheimer's disease increases mortality risk
Antipsychotic use was associated with increased risk for mortality among individuals with Alzheimer’s disease and remained increased 2 years after initiation, according to recent findings.
-
Headline News
‘Truly alarming’: Life expectancy gap in the US now up to 20 years
November 22, 20243 min read -
Headline News
Autoantibodies present in long COVID, but not a ‘smoking gun’ for new autoimmune disease
November 25, 20242 min read -
Headline News
Cardiovascular disease deaths rising among younger adults living in rural areas
November 15, 20243 min read
-
Headline News
‘Truly alarming’: Life expectancy gap in the US now up to 20 years
November 22, 20243 min read -
Headline News
Autoantibodies present in long COVID, but not a ‘smoking gun’ for new autoimmune disease
November 25, 20242 min read -
Headline News
Cardiovascular disease deaths rising among younger adults living in rural areas
November 15, 20243 min read